James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

One Good Day Isn’t Evidence of a New Uptrend

The action was bullish to be sure, but it's not to be trusted -- yet.

Why SINA (SINA), Intel (INTC) and Box (BOX) Are 3 of Today’s Worst Stocks

SINA (SINA), Intel (INTC) and Box (BOX) were battered and brisued on Thursday. Here's the deal.

5 Great Small-Cap Stocks to Buy for Growth

Small-cap stocks have underperformed for months now, but with a little role reversal on the way, small caps are the best stocks to buy as we enter the heart of 2015.

Why Logitech International SA (USA) (LOGI), Valeant Pharmaceuticals Intl Inc (VRX) and Pilgrim’s Pride Corporation (PPC) Are 3 of Today’s Worst Stocks

Logitech (LOGI), Valeant Pharmaceuticals (VRX) and Pilgrim's Pride (PPC) used more than their fair share of red ink on Wednesday. Here's why.

Why Melco Crown Entertainment (MPEL), Akorn (AKRX) and GNC Holdings (GNC) Are 3 of Today’s Worst Stocks

Melco Crown Entertainment Ltd (MPEL), Akorn, Inc. (AKRX) and GNC Holdings Inc. (GNC) just couldn't do anything right in investors' eyes on Tuesday. Here's why.